By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Astellas Pharma Inc. 

3-11 Nihonbashi-Honcho 2-chome

Chuo-ku  Tokyo  103-8411  Japan
Phone: 81-3-3244-3000 Fax: 81-3-3244-3272





Gilead (Durham, NC) 

Company News
Astellas (ALPMY) And Pfizer (PFE) Announce Amendment To Clinical Research Protocol For Phase III PROSPER Trial Of Enzalutamide In Patients With Non-Metastatic Castration-Resistant Prostate Cancer 6/9/2017 6:59:28 AM
Astellas (ALPMY) Release: Exploratory Analysis Of The Phase I/II CHRYSALIS Study Of Gilteritinib Demonstrates First Molecular Response To FLT3 Inhibitor In Acute Myeloid Leukemia 6/6/2017 9:01:38 AM
Astellas (ALPMY) And Seattle Genetics (SGEN) Announce Updated Enfortumab Vedotin Phase I Data In Metastatic Urothelial Cancer At 2017 ASCO Annual Meeting 6/5/2017 9:13:47 AM
Great Place To Work And Fortune Name Astellas (ALPMY) To Inaugural Best Workplaces In Chicago List 5/26/2017 9:28:40 AM
Astellas (ALPMY) Announces Oncology Portfolio Updates 5/18/2017 7:20:36 AM
Astellas (ALPMY) Completes Acquisition Of Ogeda 5/17/2017 6:44:59 AM
Astellas (ALPMY) Announces Key Leadership Promotions In Its Commercial Organization 5/16/2017 10:31:44 AM
Astellas (ALPMY)' Tina Karunaratne Named A 2017 Healthcare Businesswomen's Association Luminary 5/12/2017 8:58:14 AM
Astellas (ALPMY) Names Shontelle Dodson Senior Vice President And Head Of Medical Affairs Americas 5/11/2017 10:32:30 AM
Astellas (ALPMY) Dumps Lung Cancer Program After Phase III Data Fails To Impress 5/11/2017 7:28:08 AM